Monogram Orthopaedics Common Stock Profit Margin
| MGRM Stock | 2.58 0.07 2.79% |
Monogram Orthopaedics Common fundamentals help investors to digest information that contributes to Monogram Orthopaedics' financial success or failures. It also enables traders to predict the movement of Monogram Stock. The fundamental analysis module provides a way to measure Monogram Orthopaedics' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Monogram Orthopaedics stock.
| Last Reported | Projected for Next Year | ||
| Net Loss | (43.31) | (45.47) |
Monogram | Profit Margin |
Monogram Orthopaedics Common Company Profit Margin Analysis
Monogram Orthopaedics' Profit Margin measures overall efficiency of a company and shows its ability to withstand competition as well as defend against adverse conditions such as rising costs, falling prices, decline in sales or management distress. Profit margin tells investors how well the company executes on its overall pricing strategies as well as how effective the company in controlling its costs.
Current Monogram Orthopaedics Profit Margin | -45.47 |
Most of Monogram Orthopaedics' fundamental indicators, such as Profit Margin, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Monogram Orthopaedics Common is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Monogram Profit Margin Driver Correlations
Understanding the fundamental principles of building solid financial models for Monogram Orthopaedics is extremely important. It helps to project a fair market value of Monogram Stock properly, considering its historical fundamentals such as Profit Margin. Since Monogram Orthopaedics' main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Monogram Orthopaedics' historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Monogram Orthopaedics' interrelated accounts and indicators.
In a nutshell, Profit Margin indicator shows the amount of money the company makes from total sales or revenue. It can provide a good insight into companies in the same sector, as well as help to identify trends of a company from year to year.
| Competition |
Monogram Pretax Profit Margin
Pretax Profit Margin |
|
Monogram Profit Margin Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Monogram Orthopaedics' direct or indirect competition against its Profit Margin to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Monogram Orthopaedics could also be used in its relative valuation, which is a method of valuing Monogram Orthopaedics by comparing valuation metrics of similar companies.Monogram Orthopaedics is currently under evaluation in profit margin category among its peers.
Monogram Orthopaedics Current Valuation Drivers
We derive many important indicators used in calculating different scores of Monogram Orthopaedics from analyzing Monogram Orthopaedics' financial statements. These drivers represent accounts that assess Monogram Orthopaedics' ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of Monogram Orthopaedics' important valuation drivers and their relationship over time.
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Enterprise Value | 343.5M | 338.3M | 338.4M | 333.9M | 64.0M | 60.8M |
Monogram Orthopaedics ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Monogram Orthopaedics' sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Monogram Orthopaedics' managers, analysts, and investors.Environmental | Governance | Social |
Monogram Fundamentals
| Return On Equity | -1.22 | ||||
| Return On Asset | -0.61 | ||||
| Operating Margin | (40.76) % | ||||
| Current Valuation | 72.02 M | ||||
| Shares Outstanding | 34.31 M | ||||
| Shares Owned By Insiders | 34.22 % | ||||
| Shares Owned By Institutions | 3.84 % | ||||
| Number Of Shares Shorted | 153.87 K | ||||
| Price To Book | 5.07 X | ||||
| Price To Sales | 242.54 X | ||||
| Revenue | 365 K | ||||
| EBITDA | (16.86 M) | ||||
| Net Income | (13.75 M) | ||||
| Total Debt | 491.99 K | ||||
| Book Value Per Share | 0.43 X | ||||
| Cash Flow From Operations | (13.54 M) | ||||
| Short Ratio | 3.00 X | ||||
| Earnings Per Share | (0.47) X | ||||
| Target Price | 5.0 | ||||
| Number Of Employees | 28 | ||||
| Market Capitalization | 88.53 M | ||||
| Total Asset | 16.58 M | ||||
| Retained Earnings | (51.51 M) | ||||
| Working Capital | 11.8 M | ||||
| Net Asset | 16.58 M |
About Monogram Orthopaedics Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Monogram Orthopaedics Common's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Monogram Orthopaedics using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Monogram Orthopaedics Common based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Monogram Orthopaedics Piotroski F Score and Monogram Orthopaedics Altman Z Score analysis. You can also try the Balance Of Power module to check stock momentum by analyzing Balance Of Power indicator and other technical ratios.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Monogram Orthopaedics. If investors know Monogram will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Monogram Orthopaedics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.47) | Revenue Per Share 0.012 | Return On Assets (0.61) | Return On Equity (1.22) |
The market value of Monogram Orthopaedics is measured differently than its book value, which is the value of Monogram that is recorded on the company's balance sheet. Investors also form their own opinion of Monogram Orthopaedics' value that differs from its market value or its book value, called intrinsic value, which is Monogram Orthopaedics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Monogram Orthopaedics' market value can be influenced by many factors that don't directly affect Monogram Orthopaedics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Monogram Orthopaedics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Monogram Orthopaedics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Monogram Orthopaedics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.